TELA Bio Inc (TELA): Next-Year EPS Estimate 36.40%
As of 2026-03-25, TELA Bio Inc (TELA) has a next-year EPS growth estimate of 36.40%.
On 2026-03-25, analyst consensus for TELA's next-year EPS growth shifted from 30.81% to 36.40% — a positive change of 5.59 percentage points.
Current Snapshot
- Sector
- Healthcare
- Industry
- Medical Devices
- EPS growth next year
- 36.40%
- EPS growth this year
- N/A
- EPS next quarter (est)
- N/A
- Last price
- $0.69
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-03-25 | 36.40% | N/A | N/A | $0.69 |
| 2026-03-24 | 30.81% | N/A | N/A | $0.76 |
| 2026-03-24 | 30.81% | N/A | N/A | $0.76 |
| 2026-03-24 | 30.81% | N/A | N/A | $0.76 |
| 2026-03-23 | 30.81% | N/A | N/A | $0.83 |
| 2026-03-20 | 30.81% | N/A | N/A | $0.78 |
| 2026-03-19 | 30.81% | N/A | N/A | $0.75 |
| 2026-03-18 | 30.81% | N/A | N/A | $0.72 |
| 2026-03-17 | 30.81% | N/A | N/A | $0.80 |
Recent News
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is TELA Bio Inc's next-year EPS growth estimate?▾
As of 2026-03-25, TELA Bio Inc (TELA) has a next-year EPS growth estimate of 36.40%, based on analyst consensus.
When was the latest EPS estimate revision for TELA?▾
The most recent revision occurred on 2026-03-25, when analysts adjusted the next-year EPS growth estimate from 30.81% to 36.40%.
What sector and industry does TELA Bio Inc belong to?▾
TELA Bio Inc operates in the Healthcare sector, specifically the Medical Devices industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. TELA appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. TELA Bio Inc (TELA) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports